388 related articles for article (PubMed ID: 15871748)
1. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
Nakipoglu Y; Derbentli S; Cagatay AA; Katranci H
BMC Infect Dis; 2005 May; 5():31. PubMed ID: 15871748
[TBL] [Abstract][Full Text] [Related]
2. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
[TBL] [Abstract][Full Text] [Related]
5. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Tiwari HK; Sen MR
BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
[TBL] [Abstract][Full Text] [Related]
6. Glycopeptide resistance in coagulase-negative staphylococci.
Biavasco F; Vignaroli C; Varaldo PE
Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
[TBL] [Abstract][Full Text] [Related]
7. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
8. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
Nonhoff C; Denis O; Struelens MJ
Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of reduced vancomycin susceptibility in methicillin-resistant staphylococci].
Kuşcu F; Oztürk DB; Gürbüz Y; Tütüncü EE; Sencan I; Gül S
Mikrobiyol Bul; 2011 Apr; 45(2):248-57. PubMed ID: 21644067
[TBL] [Abstract][Full Text] [Related]
10. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
Biavasco F; Vignaroli C; Lazzarini R; Varaldo PE
Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
[TBL] [Abstract][Full Text] [Related]
11. Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals.
Borg MA; Zerafa R; Morrison D; Cuschieri P
Clin Microbiol Infect; 2005 May; 11(5):405-7. PubMed ID: 15819869
[TBL] [Abstract][Full Text] [Related]
12. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
[TBL] [Abstract][Full Text] [Related]
13. Selection of resistance to glycopeptide antibiotics in staphylococci.
Biavasco F; Giovanetti E; Varaldo PE
J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
[TBL] [Abstract][Full Text] [Related]
14. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
Fitzgibbon MM; Rossney AS; O'Connell B
J Clin Microbiol; 2007 Oct; 45(10):3263-9. PubMed ID: 17687008
[TBL] [Abstract][Full Text] [Related]
15. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002.
Robert J; Bismuth R; Jarlier V
J Antimicrob Chemother; 2006 Mar; 57(3):506-10. PubMed ID: 16410265
[TBL] [Abstract][Full Text] [Related]
16. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.
Trakulsomboon S; Danchaivijitr S; Rongrungruang Y; Dhiraputra C; Susaemgrat W; Ito T; Hiramatsu K
J Clin Microbiol; 2001 Feb; 39(2):591-5. PubMed ID: 11158112
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
[TBL] [Abstract][Full Text] [Related]
18. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
Tabe Y; Nakamura A; Igari J
J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
[TBL] [Abstract][Full Text] [Related]
20. [Determination of the susceptibility of staphylococci and enterococci to plycopeptides by the E-test method].
Plotton N; Cavallo JD; Crenn Y; Meyran M
Pathol Biol (Paris); 1994 May; 42(5):468-70. PubMed ID: 7824315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]